VESALIUS Biocapital IV Partners Sarl

Portfolio

We are building a diversified portfolio addressing unmet medical needs

inHEART

inHEART
inHEART’s current therapeutic solution addresses the challenges of conventional cardiac ablations. The inHEART solution creates highly detailed, interactive 3D heart models with proprietary AI-driven cardiac CT or MR image segmentation. These 3D models of the heart allow physicians to optimize treatment strategies based on each patient’s unique cardiac anatomy and to support pre-procedural planning for faster ablation procedures and improved clinical outcomes.

Year Founded

2017

Year Invested

2024

Country

France

Sector

Health Tech.

Website & Contacts